Optimization of Contrast Agent Dose in CT With Lean Body Weight
Status:
Completed
Trial end date:
2019-02-25
Target enrollment:
Participant gender:
Summary
This study evaluates the different enhancement using a contrast agent dose in computed
tomography based on total body weight or based on lean body weight. Half of participants will
receive contrast agent dose based on their total body weight, while the other half will
receive a dose based on their lean body weight. Our hypothesis is that if contrast agent is
administered not basing on total body weight but on lean body weight it is possible to obtain
equal or better quality of enhanced images, a reduction of the variability of contrast
enhancement, and also a dose reduction in some patients (overweight ones).